L & S Advisors Inc grew its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 125.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,931 shares of the healthcare conglomerate’s stock after purchasing an additional 19,406 shares during the period. UnitedHealth Group comprises about 1.1% of L & S Advisors Inc’s portfolio, making the stock its 13th biggest position. L & S Advisors Inc’s holdings in UnitedHealth Group were worth $8,523,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Canton Hathaway LLC purchased a new stake in shares of UnitedHealth Group during the first quarter worth approximately $36,000. Coastal Capital Group Inc. purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $45,000. Creative Financial Designs Inc. ADV increased its stake in shares of UnitedHealth Group by 89.6% during the first quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after buying an additional 95 shares during the period. Capital Advisors Ltd. LLC increased its stake in shares of UnitedHealth Group by 235.7% during the second quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock worth $57,000 after buying an additional 165 shares during the period. Finally, Financial Gravity Wealth Inc. purchased a new stake in shares of UnitedHealth Group during the first quarter worth approximately $58,000. Institutional investors own 86.04% of the company’s stock.
UNH stock opened at $235.12 on Friday. The company has a market capitalization of $220.30 billion, a P/E ratio of 18.25, a PEG ratio of 1.24 and a beta of 0.62. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The business has a 50 day simple moving average of $241.01 and a 200-day simple moving average of $243.65. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company’s revenue was up 8.0% compared to the same quarter last year. During the same period in the prior year, the company earned $3.14 earnings per share. Research analysts predict that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $1.08 dividend. This represents a $4.32 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Friday, September 13th. UnitedHealth Group’s payout ratio is currently 33.54%.
In related news, Director Richard T. Burke sold 2,000 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $231.50, for a total transaction of $463,000.00. Following the completion of the sale, the director now directly owns 187,979 shares of the company’s stock, valued at $43,517,138.50. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the sale, the director now directly owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The disclosure for this sale can be found here. Insiders sold 19,000 shares of company stock valued at $4,758,720 over the last three months. Corporate insiders own 0.87% of the company’s stock.
UNH has been the subject of a number of research analyst reports. Cantor Fitzgerald set a $310.00 price target on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Credit Suisse Group set a $293.00 price target on UnitedHealth Group and gave the company a “buy” rating in a report on Thursday, August 29th. ValuEngine downgraded UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, September 5th. Raymond James upped their price target on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a report on Friday, July 19th. Finally, Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 15th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eighteen have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $292.47.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Diversification in Investing
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.